Quick Answer
Adicet Bio, Inc. reported Diluted EPS of $16.95 per share (loss) for fiscal year 2025.
Adicet Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$16.95 | +20.5% |
| 2024 | -$21.33 | -544.4% |
| 2023 | -$3.31 | -94.7% |
| 2022 | -$1.70 | +15.0% |
| 2021 | -$2.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.29 | +14.7% | +14.7% |
| June 30, 2025 | -$0.34 | -3.0% | -9.7% |
| March 31, 2025 | -$0.31 | +11.4% | +8.8% |
| September 30, 2024 | -$0.34 | +70.7% | -3.0% |
| June 30, 2024 | -$0.33 | +56.0% | +5.7% |
| March 31, 2024 | -$0.35 | +51.4% | +69.8% |
| September 30, 2023 | -$1.16 | -118.9% | -54.7% |
| June 30, 2023 | -$0.75 | -33.9% | -4.2% |
- Adicet Bio, Inc. showed an increase of +20.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Adicet Bio, Inc.’s diluted eps has declined by 747.5% (from $2.00 per share (loss) to $16.95 per share (loss)).
- The most recent figure is from Adicet Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: